Histopathology and molecular pathology of pediatric pineal parenchymal tumors
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Pineal parenchymal tumors in children are rare. They consist of two main types, pineoblastoma (PB) and pineal parenchymal tumor of intermediate differentiation (PPTID), which are World Health Organization (WHO) grade 4 and grade 2-3 respectively. PBs are divided into four distinct molecular groups: PB-miRNA1, PB-miRNA2, PB-RB1, and PB-MYC/FOXR2. PB-RB1 and PB-MYC/FOXR2 affect young children and are associated with a dismal prognosis. PB-miRNA1 and PB-miRNA2 groups affect older children and follow a more favorable course. They are characterized by mutually exclusive alterations in genes involved in miRNA biogenesis, including DICER1, DROSHA, and DGCR8. They may be sporadic or may represent one manifestation of DICER1 syndrome. PB-RB1 tumors show alterations in the RB1 gene and may develop in the setting of congenital retinoblastoma, a condition known as "trilateral retinoblastoma." In the pediatric population, PPTIDs typically affect adolescents. They are characterized by small in-frame insertions in the KBTBD4 gene which is involved in ubiquitination.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These mutations occur almost exclusively in G3/G4-2 and G3/G4-7 medulloblastomas and have been observed in pediatric and adult cases of pineal parenchymal tumors of intermediate differentiation (23–25).”
From The Medulloblastoma Meta-Analysis Portal Enables Integrative Exploration of Clinical and Genomic Data from Patients (2025) · cites this paper as [25]
In the citing paper
“The most prevalent mutation, an insertion at R313insPRR (7, 23–26), has been functionally characterized as enabling interaction with neosubstrates, such as small corepressor coREST.”
From The Medulloblastoma Meta-Analysis Portal Enables Integrative Exploration of Clinical and Genomic Data from Patients (2025) · cites this paper as [25]
Citations
Cites
The 2021 WHO classification of tumors of the central nervous system: a summary
Louis, D. N., Perry, A., Wesseling, P., Brat, D. J., Cree, I. A., Figarella-Branger, D., Hawkins, C., Ng, H. K., Pfister, S. M., Reifenberger, G., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab106 · Cited by 12,273
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
O'Brien, J., Hayder, H., Zayed, Y., & Peng, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00402 · Cited by 5,287 · cited 1×
“Canonical processing of miRNAs: how does it work? MiRNAs are small, single-stranded, noncoding RNAs that have a mean length of 22 nucleotides [19].”
BackgroundThe whole-genome landscape of medulloblastoma subtypes
Northcott, P. A., Buchhalter, I., Morrissy, A. S., Hovestadt, V., Weischenfeldt, J., Ehrenberger, T., Gröbner, S., Segura-Wang, M., Zichner, T., Rudneva, V. A., et al. (2017) · Nature · doi:10.1038/nature22973 · Cited by 1,112 · cited 1×
“These alterations are not specific to PPTIDs since they have also been demonstrated in some group 3 and group 4 medulloblastomas (21% of subtype II and 14% of subtype VII, respectively) [32].”
BackgroundNew Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
Sturm, D., Orr, B. A., Toprak, U. H., Hovestadt, V., Jones, D. T. W., Capper, D., Sill, M., Buchhalter, I., Northcott, P. A., Leis, I., et al. (2016) · Cell · doi:10.1016/j.cell.2016.01.015 · Cited by 975
Dimaras, H., Kimani, K., Dimba, E. A., Gronsdahl, P., White, A., Chan, H. S., & Gallie, B. L. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61137-9 · Cited by 669
Life of RISC: Formation, action, and degradation of RNA-induced silencing complex
Iwakawa, H.-O., & Tomari, Y. (2022) · Molecular Cell · doi:10.1016/j.molcel.2021.11.026 · Cited by 488 · cited 1×
“MicroRNA and AGO (Argonaute) protein assemble into a molecular complex known as miRISC (miRNA-induced gene silencing complex) [20].”
BackgroundRecurrent DGCR8, DROSHA, and SIX Homeodomain Mutations in Favorable Histology Wilms Tumors
Walz, A. L., Ooms, A., Gadd, S., Gerhard, D. S., Smith, M. A., Guidry Auvil, J. M., Meerzaman, D., Chen, Q.-R., Hsu, C. H., Yan, C., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.01.003 · Cited by 284 · cited 1×
“E518K hotspot missense mutation located in the double-stranded RNA binding domain [25].”
BackgroundPineal Parenchymal Tumors: A Correlation of Histological Features with Prognosis in 66 Cases
Jouvet, A., Saint‐Pierre, G., Fauchon, F., Privat, K., Bouffet, E., Ruchoux, M., Chauveinc, L., & Fèvre‐Montange, M. (2000) · Brain Pathology · doi:10.1111/j.1750-3639.2000.tb00242.x · Cited by 254 · cited 3×
“Pineoblastoma is an embryonal tumor composed of diffuse sheets of poorly differentiated neuroepithelial neoplastic cells [9].”
BackgroundInfluentialParenchymal pineal tumors: a clinicopathological study of 76 cases
Fauchon, F., Jouvet, A., Paquis, P., Saint-Pierre, G., Mottolese, C., Ben Hassel, M., Chauveinc, L., Sichez, J.-P., Philippon, J., Schlienger, M., et al. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00389-2 · Cited by 232 · cited 1×
“Using this grading system, local recurrence and spinal dissemination were observed in 22% and 33% of grade 3 PPTIDs, respectively [39].”
MethodPapillary Tumor of the Pineal Region
Jouvet, A., Fauchon, F., Liberski, P., Saint-Pierre, G., Didier-Bazes, M., Heitzmann, A., Delisle, M.-B., Biassette, H. A., Vincent, S., Mikol, J., et al. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200304000-00011 · Cited by 225 · cited 1×
“This neoplasm is thought to arise from the specialized ependymocytes of the subcommissural organ, a circumventricular organ located in the posterior part of the third ventricle below the posterior commissure and at the entrance of the aqueduct of Sylvius [48].”
BackgroundGerm-line and somatic DICER1 mutations in pineoblastoma
de Kock, L., Sabbaghian, N., Druker, H., Weber, E., Hamel, N., Miller, S., Choong, C. S., Gottardo, N. G., Kees, U. R., Rednam, S. P., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1318-7 · Cited by 179
Trilateral retinoblastoma: a systematic review and meta-analysis
de Jong, M. C., Kors, W. A., de Graaf, P., Castelijns, J. A., Kivelä, T., & Moll, A. C. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70336-5 · Cited by 177 · cited 2×
“The risk of developing intracranial midline embryonal tumors in children with RB1 germline mutations is approximately 5% [29].”
BackgroundmiR-17∼92 cooperates with RB pathway mutations to promote retinoblastoma
Conkrite, K., Sundby, M., Mukai, S., Thomson, J. M., Mu, D., Hammond, S. M., & MacPherson, D. (2011) · Genes & Development · doi:10.1101/gad.17027411 · Cited by 174
Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour
Torrezan, G. T., Ferreira, E. N., Nakahata, A. M., Barros, B. D. F., Castro, M. T. M., Correa, B. R., Krepischi, A. C. V., Olivieri, E. H. R., Cunha, I. W., Tabori, U., et al. (2014) · Nature Communications · doi:10.1038/ncomms5039 · Cited by 173 · cited 1×
“This mutation affects a metal-binding residue in the RNase IIIb domain and results in decreased formation of mature miRNAs by impairing pri-miRNA cleavage [24].”
BackgroundTen years of DICER1 mutations: Provenance, distribution, and associated phenotypes
de Kock, L., Wu, M. K., & Foulkes, W. D. (2019) · Human Mutation · doi:10.1002/humu.23877 · Cited by 148
Evolution of photosensory pineal organs in new light: the fate of neuroendocrine photoreceptors
Ekström, P., & Meissl, H. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1303 · Cited by 147 · cited 2×
“Human pinealocytes have acquired a “pure” neuroendocrine phenotype and synthesize melatonin under the indirect regulation of the retina through the suprachiasmatic nucleus/superior cervical ganglion pathway [2].”
BackgroundLi, B. K., Vasiljevic, A., Dufour, C., Yao, F., Ho, B., Lu, M., Hwang, E. I., Gururangan, S., Hansford, J. R., Fouladi, M., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02111-y · Cited by 124 · cited 4×
“1 3 as XPO5, have been more rarely described; however, their pathogenic effect is unclear [7].”
BackgroundInfluentialSelf-citationPrevalence of pineal cysts in children and young adults
Al‐Holou, W. N., Garton, H. J. L., Muraszko, K. M., Ibrahim, M., & Maher, C. O. (2009) · Journal of Neurosurgery Pediatrics · doi:10.3171/2009.4.peds0951 · Cited by 106 · cited 2×
“Pineal cysts are non-neoplastic lesions identified in 2% of children and young adults by MRI [43].”
BackgroundCystic lesions of the pineal region - MRI and pathology
Engel, U., Gottschalk, S., Niehaus, L., Lehmann, R., May, C., Vogel, S., & Jänisch, W. (2000) · Neuroradiology · doi:10.1007/s002340000308 · Cited by 101 · cited 4×
“PCs typically affect adults with a median age of 55.5 years [14].”
BackgroundInfluentialClinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study
Liu, A. P. Y., Li, B. K., Pfaff, E., Gudenas, B. L., Vasiljevic, A., Orr, B. A., Dufour, C., Snuderl, M., Karajannis, M. A., Rosenblum, M. K., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02284-5 · Cited by 94 · cited 9×
“Recently, an international collaborative effort by several research teams has led to a better understanding of the molecular mechanisms underlying the development of PBs [7, 8, 14, 15].”
BackgroundInfluentialSelf-citationPfaff, E., Aichmüller, C., Sill, M., Stichel, D., Snuderl, M., Karajannis, M. A., Schuhmann, M. U., Schittenhelm, J., Hasselblatt, M., Thomas, C., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-019-02101-0 · Cited by 92
Structural and ultrastructural characteristics of human pineal gland, and pineal parenchymal tumors
Jouvet, A., Derrington, E. A., Pialat, J., Lapras, C., Fèvre‐Montange, M., Besan�on, R., Belin, M., & Saint-Pierre, G. (1994) · Acta Neuropathologica · doi:10.1007/bf00310377 · Cited by 89 · cited 2×
“As is seen in the normal pineal gland, PPTs may show some photoreceptor differentiation [3].”
BackgroundRecurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma
Snuderl, M., Kannan, K., Pfaff, E., Wang, S., Stafford, J. M., Serrano, J., Heguy, A., Ray, K., Faustin, A., Aminova, O., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05029-3 · Cited by 77
Fauchon, F., Hasselblatt, M., Jouvet, A., Champier, J., Popović, M., Kirollos, R. W., Santarius, T., Amemiya, S., Kumabe, T., Frappaz, D., et al. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1050-5 · Cited by 75
Self-citationLee, J. C., Mazor, T., Lao, R., Wan, E., Diallo, A. B., Hill, N. S., Thangaraj, N., Wendelsdorf, K., Samuel, D., Kline, C. N., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01990-5 · Cited by 71 · cited 2×
“In contrast to pineal parenchymal tumors of intermediate differentiation (see specific section below), PB does not harbor alterations in KBTBD4 gene [23].”
BackgroundMallick, S., Benson, R., & Rath, G. K. (2016) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2016.10.025 · Cited by 69
Germline DICER1 mutation and associated loss of heterozygosity in a pineoblastoma: Figure 1
Sabbaghian, N., Hamel, N., Srivastava, A., Albrecht, S., Priest, J. R., & Foulkes, W. D. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-100898 · Cited by 68
Liu, A. P. Y., Gudenas, B. L., Lin, T., Orr, B. A., Klimo, P. D., Kumar, R., Bouffet, É., Gururangan, S., Crawford, J. R., Kellie, S. J., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02106-9 · Cited by 68
Papillary Tumor of the Pineal Region: A Distinct Molecular Entity
Heim, S., Sill, M., Jones, D., Vasiljevic, A., Jouvet, A., Fèvre‐Montange, M., Wesseling, P., Beschorner, R., Mittelbronn, M. G. A., Kohlhof, P., et al. (2015) · Brain Pathology · doi:10.1111/bpa.12282 · Cited by 63 · cited 2×
“The molecular profile is mainly characterized by loss of chromosome 10 and, in some cases, mutations in PTEN [49, 50].”
BackgroundSelf-citationCRX Is a Diagnostic Marker of Retinal and Pineal Lineage Tumors
Santagata, S., Maire, C. L., Idbaïh, A., Geffers, L., Correll, M., Holton, K. M., Quackenbush, J. F., & Ligon, K. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007932 · Cited by 60 · cited 2×
“The nuclear expression of CRX in PPTs and retinoblastomas further underlies the close relationship between pinealocytes and retinal photoreceptor cells [4].”
BackgroundUtility of Ki67 immunostaining in the grading of pineal parenchymal tumours: a multicentre study
Fèvre‐Montange, M., Vasiljevic, A., Frappaz, D., Champier, J., Szathmári, A., Aubriot‐Lorton, M., Chapon, F., Coulon, A., Quintin‐Roué, I., Delisle, M., et al. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01202.x · Cited by 58
Self-citationClinicopathologic Study of Pineal Parenchymal Tumors of Intermediate Differentiation
Ito, T., Kanno, H., Sato, K.-I., Oikawa, M., Ozaki, Y., Hirohiko, N., Terasaka, S., Kobayashi, H., Houkin, K., Hatanaka, K. C., et al. (2013) · World Neurosurgery · doi:10.1016/j.wneu.2013.02.007 · Cited by 57
Fèvre‐Montange, M., Szathmári, A., Champier, J., Mokhtari, K., Chrétien, F. C., Coulon, A., Figarella-Branger, D. F., Polivka, M., Varlet, P., Uro‐Coste, E., et al. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00128.x · Cited by 57
Goschzik, T., Gessi, M., Denkhaus, D., & Pietsch, T. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000093 · Cited by 56 · cited 2×
“The molecular profile is mainly characterized by loss of chromosome 10 and, in some cases, mutations in PTEN [49, 50].”
BackgroundArray comparative genomic hybridization in retinoma and retinoblastoma tissues
Sampieri, K., Amenduni, M., Papa, F. T., Katzaki, E., Mencarelli, M. A., Marozza, A., Epistolato, M. C., Toti, P., Lazzi, S., Bruttini, M., et al. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2008.01070.x · Cited by 48 · cited 1×
“The PB-RB1 group shares similar chromosomal imbalances with retinoblastoma, showing chromosome 16 loss and chromosome 1q and 6p gains [26].”
BackgroundYu, T., Sun, X., Wang, J., Ren, X., Lin, N., & Lin, S. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309805 · Cited by 45
Chen, Z., Ioris, R. M., Richardson, S., Van Ess, A. N., Vendrell, I., Kessler, B. M., Buffa, F. M., Busino, L., Clifford, S. C., Bullock, A. N., et al. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00983-4 · Cited by 41 · cited 2×
“In medulloblastomas, KBTBD4 insertion acts as a neomorphic mutation leading to the recognition of neo-substrates such as CoREST (Corepressor of RE1 silencing transcription factor) [34].”
BackgroundPineal parenchymal tumors – utility of immunohistochemical markers in prognostication
Arivazhagan, A., Anandh, B., Santosh, V., & Chandramouli, B. A. (2008) · Clinical Neuropathology · doi:10.5414/npp27325 · Cited by 36
Management of pineal and colloid cysts
Jenkinson, M. D., Mills, S. J., Mallucci, C. L., & Santarius, T. (2021) · Practical Neurology · doi:10.1136/practneurol-2020-002838 · Cited by 33 · cited 1×
“They are mainly found incidentally but are also symptomatic in a few cases, causing hydrocephalus and requiring neurosurgical treatment [44].”
BackgroundAsymptomatic and symptomatic glial cysts of the pineal gland.
Taraszewska, A., Matyja, E., Koszewski, W., Zaczyński, A., Bardadin, K. A., & Czernicki, Z. (2008) · PubMed · Cited by 32
The epidemiology of primary and metastatic brain tumors in infancy through childhood
Lamba, N., Groves, A. P., Torre, M., Yeo, K. K., & Iorgulescu, J. B. (2022) · Journal of Neuro-Oncology · doi:10.1007/s11060-021-03927-z · Cited by 29 · cited 2×
“Among PPTs, pineoblastomas and pineal parenchymal tumors of intermediate differentiation are the two main histological subtypes found in the pediatric population [1].”
BackgroundPineoblastoma is uniquely tolerant of mutually exclusive loss of DICER1, DROSHA or DGCR8
de Kock, L., Rivera, B., & Foulkes, W. D. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02139-5 · Cited by 27
Review of Pineal Anlage Tumor With Divergent Histology
Berns, S. H., & Pearl, G. S. (2006) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2006-130-1233-ropatw · Cited by 24
Coy, S., Dubuc, A. M., Dahiya, S. M., Ligon, K. L., Vasiljevic, A., & Santagata, S. (2017) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000903 · Cited by 23 · cited 2×
“Their ependymal nature is underlined by the expression of the transcription factor FOX-J1 and the absence of CRX immunopositivity [10].”
BackgroundSelf-citationLopez‐Nunez, O. F., Alaggio, R., John, I., Ciolfi, A., Pedace, L., Mastronuzzi, A., Gianno, F., Giangaspero, F., Rossi, S., Donofrio, V., et al. (2021) · Cancers · doi:10.3390/cancers13040706 · Cited by 21
Liu, A. P. Y., Priesterbach-Ackley, L. P., Orr, B. A., Li, B. K., Gudenas, B. L., Reddingius, R. E., Suñol, M., Lavarino, C. E., Olaciregui, N. G., López, V. S., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02208-9 · Cited by 18
Mathkour, M., Hanna, J., Ibrahim, N., Scullen, T. A., Kilgore, M. D., Werner, C., Cormier, I., Spencer, P., Keen, J. R., & Bui, C. J. (2020) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2020.106404 · Cited by 16
Epidemiology of pineoblastoma in the United States, 2000–2017
Greppin, K., Cioffi, G., Waite, K. A., Ostrom, Q. T., Landi, D. B., Takaoka, K., Kruchko, C. A., & Barnholtz‐Sloan, J. S. (2022) · Neuro-Oncology Practice · doi:10.1093/nop/npac009 · Cited by 16
ATRX Mutations in Pineal Parenchymal Tumors of Intermediate Differentiation
Martínez, H., Nagurney, M., Wang, Z., Eberhart, C. G., Heaphy, C. M., Curtis, M. T., & Rodríguez, F. J. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz050 · Cited by 13 · cited 1×
“ATRX (α-thalassemia/mental retardation syndrome, X-linked) frameshift mutations have rarely been detected in PPTID [37].”
BackgroundUchida, E., Sasaki, A., Shirahata, M., Suzuki, T., Adachi, J.-I., Mishima, K., Yasuda, M., Fujimaki, T., Ichimura, K., & Nishikawa, R. (2022) · Brain Tumor Pathology · doi:10.1007/s10014-021-00421-2 · Cited by 5 · cited 1×
“The use of determination of KBTBD4-status may thus be a promising tool for differential diagnosis between PB and PPTID [36].”
Method
Research works printed but not linked: 2
- Garancher A, Lin CY, Morabito M, Richer W, Rocques N, Larcher M, Bihannic L, Smith K, Miquel C, Leboucher S, Herath NI, Dupuy F, Varlet P, Haberler C, Walczak C, El Tayara N, Volk A, Puget S, Doz F, Delattre O, Druillennec S, Ayrault O, Wechsler-Reya RJ, Eychene A, Bourdeaut F, Northcott PA, Pouponnot C (2018) NRL and CRX define photoreceptor identity and reveal subgroup-specific dependencies in medulloblastoma. Cancer Cell 33(435–449):e436
- Song Y, Dagil L, Fairall L, Robertson N, Wu M, Ragan TJ, Savva CG, Saleh A, Morone N, Kunze MBA, Jamieson AG, Cole PA, Hansen DF, Schwabe JWR (2020) Mechanism of crosstalk between the LSD1 demethylase and HDAC1 deacetylase in the CoREST complex. Cell Rep 30(2699–2711):e2698
Cited by
The Molecular Basis of Pediatric Brain Tumors: A Review with Clinical Implications
Antoniades, E., Keffes, N., Vorri, S. C., Tsitouras, V., Gkantsinikoudis, N., Tsitsopoulos, P., & Magras, J. (2025) · Cancers · doi:10.3390/cancers17091566 · Cited by 6
Insights into the molecular roles of FOXR2 in the pathology of primary pediatric brain tumors
Gharbaran, R. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104188 · Cited by 3
Gangwani, K., Lu, C., Dhanda, S. K., Sioson, E., Zaldívar Peraza, A., Matt, G. Y., Paul, R., Wang, J., Reilly, C., Acić, A., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-4976 · Cited by 1
“These mutations occur almost exclusively in G3/G4-2 and G3/G4-7 medullo-blastomas and have been observed in pediatric and adult cases of pineal parenchymal tumors of intermediate differentiation (23–25).”
Levashov, A., Serov, Y. A., Ushakova, T. L., Зеленова, Е. Е., Горовцова, О. В., Yugay, O. V., Polyakov, V. G., Ryzhova, M. V., Строганова, А. М., Alekseeva, E. A., et al. (2024) · Russian Journal of Pediatric Hematology and Oncology · doi:10.21682/2311-1267-2024-11-3-46-59 · Cited by 1
Histopathology and Molecular Pathology of Pineal Region Tumors
Vasiljevic, A. (2026) · Advances and technical standards in neurosurgery · doi:10.1007/978-3-032-18608-9_7 · Cited by 1
Self-citation
Metadata
- Authors
- Vasiljevic, A.
- Affiliations
- Hospices Civils de Lyon (FR)
- Corresponding author
- Vasiljevic, Alexandre
- Venue
- Child's Nervous System
- Published
- 2022-08-16
- Volume
- 39
- Issue
- 9
- Pages
- 2273-2284
- ISSN
- 0256-7040 (ISSN-L)
- 1433-0350
- OpenAlex
- W4292178890
- Cited by
- 18
- References
- 50
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 4 · 2023: 4
- FWCI
- 0.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Child s Nervous System (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Ophthalmology › Ocular Oncology and Treatments
- Health Sciences › Medicine › Surgery › Testicular diseases and treatments
- Keywords
- pineal parenchymal tumors, pineoblastoma, pineal parenchymal tumor of intermediate differentiation, pediatric brain tumors, histopathology, molecular pathology, microRNA biogenesis, DICER1, Drosha, DGCR8, DICER1 syndrome, RB1, trilateral retinoblastoma, prognosis
- MeSH terms
- Adolescent, Brain Neoplasms, Child, Child, Preschool, Humans, Pineal Gland, Pinealoma, Retinoblastoma, RNA-Binding Proteins, Retinal Neoplasms, MicroRNAs, Ribonuclease III, Forkhead Transcription Factors, DEAD-box RNA Helicases, Pathology, Molecular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.